Surgeon Performs Live Sleeve Gastrectomy Telesurgery at International Conference Using TransEnterix's New Flex Ligating Shears
27 Agosto 2014 - 6:00AM
Business Wire
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company
pioneering the use of robotics and flexible instruments to improve
minimally invasive surgery, today announced the broadcast of a
successful sleeve gastrectomy surgery by Dr. Helmuth Billy at the
5th International Conference on Sleeve Gastrectomy to help kick off
the 2014 19th World Congress of the International Federation for
the Surgery of Obesity & Metabolic Disorders (IFSO) meeting in
Montreal, Canada. Dr. Billy performed the innovative surgery from
across the globe at Hamad General Hospital in Doha, Qatar using
TransEnterix’s Flex Ligating Shears, the only fully flexible
advanced energy device available that offers ligation and division
with direct thermal fusion.
Seen globally by more than 400 surgeons, this was the first
broadcast of a case utilizing the Flex Ligating Shears advanced
energy device at a major bariatric surgical conference. The Flex
Ligating Shears received 510(k) clearance from the U.S. Food and
Drug Administration and is the only advanced energy device that
completely articulates 360 degrees to provide optimal angles and
access to surgeons within the operating field.
“The Transenterix Flex Ligating Shears allows for significantly
more complex tasks to be performed utilizing the flexible
articulating channels of their platform,” said Dr. Helmuth Billy,
Director of Bariatric Surgery at St. John’s Regional Medical Center
in Oxnard, CA. “The device gives me a fully flexible and
controllable tissue sealing option that works well at limiting
bleeding and creates little to no smoke that would impair my
vision.”
“We are pleased Dr. Billy was chosen to perform a live gastric
sleeve procedure using the new TransEnterix Flex Ligating Shears at
such a prestigious global surgical conference,” said Todd M. Pope,
President and CEO of TransEnterix. "Advanced energy is utilized in
some of the most critical tasks amongst the millions of minimally
invasive surgeries performed worldwide. Our flexible device, which
utilizes thermal fusion technology, allows surgeons to precisely
deliver energy at the desired angles. We believe this device is
preparing TransEnterix to be a meaningful player in the
multi-billion dollar advanced energy market, especially when
combined with the advantages of robotic assistance with our
SurgiBot system expected to be launched in 2015.”
Advanced energy devices represent one of the most versatile and
crucial tools for surgeons in minimally invasive surgery. These
devices deliver controlled energy to effectively ligate and divide
tissue while greatly limiting bleeding in the operative field and
minimizing thermal injury to surrounding structures.
TransEnterix’s advanced energy device has been created for use
with the company’s existing surgical system to support the
expansion of single incision surgery for reduced incisions and
scarring. The company intends to offer a similar device in the
future for its SurgiBot™ system, a new patient-side robotic surgery
system currently under development.
About TransEnterix
TransEnterix is a medical device company that is pioneering the
use of flexible instruments and robotics to improve minimally
invasive surgery. The company is focused on the development and
commercialization of the SurgiBot system, a minimally invasive
surgical robotic system that allows the surgeon to be patient-side
within the sterile field. For more information, visit the company's
website at www.transenterix.com
Forward Looking Statements
This press release includes statements relating to our advanced
energy device and SurgiBot system, as well as our current
regulatory and commercialization plans for the system. These
statements and other statements regarding our future plans and
goals constitute “forward looking statements” within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and are intended to qualify for
the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Such statements are
subject to risks and uncertainties that are often difficult to
predict, are beyond our control, and which may cause results to
differ materially from expectations, including whether TransEnterix
will become a meaningful player in the advanced energy market,
especially when combined with the advantages of robotic assistance
with our SurgiBot system expected to be launched in 2015. Factors
that could cause our results to differ materially from those
described include but are not limited to: the pace of adoption of
our product technology by surgeons, including the Flex Ligating
Shears Advanced Energy Device; whether the Flex Ligating Shears can
offer surgeons the ability to attain precise angles when cutting
and dividing tissue in a laparoscopic procedure; the success and
market opportunity of our continuing and new product development
efforts, including the SurgiBot system; the effect on our business
of existing and new regulatory requirements; and other economic and
competitive factors. For a discussion of the most significant risks
and uncertainties associated with TransEnterix's business, please
review our filings with the Securities and Exchange Commission
(SEC), including our Annual Report on Form 10-K for the year ended
December 31, 2013 filed on March 5, 2014, as amended; and
subsequent SEC reports. You are cautioned not to place undue
reliance on these forward-looking statements, which are based on
our expectations as of the date of this press release and speak
only as of the date of this press release. We undertake no
obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise.
Media Contact:Grey Matter MarketingJoanna Rice,
951-751-1858Joanna@greymattermarketing.comorInvestor
Contact:Westwicke PartnersMark Klausner,
443-213-0501transenterix@westwicke.com
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024